Apopa Patrick L, He Xiaoqing, Ma Qiang
Receptor Biology Laboratory, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV 26505, USA.
J Biochem Mol Toxicol. 2008 Feb;22(1):63-76. doi: 10.1002/jbt.20212.
The antioxidant-activated transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) regulates the induction of cytoprotective genes against chemical toxicity and oxidative injuries. The role of phosphorylation in Nrf2 activation has been suggested but remains elusive. We report that phenolic antioxidant/pro-oxidant tert-butylhydroquinone (tBHQ) induced two forms of the Nrf2 protein in neuroblastoma cells (IMR-32), which migrated as distinctive bands on SDS-PAGE. In vitro treatment with lambda phosphatase eliminated the slower migrating form and increased the amount of the faster migrating form of Nrf2. In vivo (32)Pi-phosphorylation resulted in (32)Pi-labeling of the Nrf2 protein in the presence of tBHQ that can be dephosphorylated by lambda phosphotase, indicating that the slower migrating form is a phosphorylated Nrf2 protein and the faster form an unphosphorylated Nrf2. Unphosphorylated Nrf2 predominated in the cytoplasm, whereas the phosphorylated form preferentially localized in the nucleus. Nuclear Nrf2 can be dephosphorylated by lambda phosphotase in vitro and be converted to the faster migrating form, implicating phosphorylation of Nrf2 in the cytoplasmic-nuclear translocation of the protein. Deletional analyses from both the carboxyl- and amino-ends revealed the transcription activation (TA) domains Neh4 (Nrf2-ECH homology 4) and Neh5 (Nrf2-ECH homology 5) as a major region necessary for the phosphorylation. The TA domains are characterized by the presence of multiple phosphorylation sites of casein kinase 2 (CK2). Moreover, CK2 phosphorylated the TA domains in vitro. Treatment with CK2 inhibitor 2-dimethylamino-4,5,6,7,-tetrabromo-1H-benzimidazole (DMAT) blocked the induction of endogenous target genes of Nrf2 in cells and inhibited the TA activities of both the full length and the TA domains of Nrf2 to a large extent. Finally, phosphorylation of the TA domains correlated with the nuclear translocation of Nrf2 that was inhibited by DMAT in a concentration-dependent manner. The findings demonstrated that phosphorylation of Nrf2 at the TA domains by CK2 is an integral component of Nrf2 activation necessary for the nuclear localization and transcription activation function of Nrf2 in neuroblastoma cells.
抗氧化剂激活的转录因子核因子红细胞2相关因子2(Nrf2)可调节细胞保护基因的诱导,以抵抗化学毒性和氧化损伤。磷酸化在Nrf2激活中的作用已被提出,但仍不清楚。我们报告说,酚类抗氧化剂/促氧化剂叔丁基对苯二酚(tBHQ)在神经母细胞瘤细胞(IMR-32)中诱导了两种形式的Nrf2蛋白,它们在SDS-PAGE上迁移为独特的条带。用λ磷酸酶进行体外处理消除了迁移较慢的形式,并增加了Nrf2迁移较快形式的量。体内(32)Pi磷酸化导致在tBHQ存在下Nrf2蛋白的(32)Pi标记,该标记可被λ磷酸酶去磷酸化,表明迁移较慢的形式是磷酸化的Nrf2蛋白,而迁移较快的形式是未磷酸化的Nrf2。未磷酸化的Nrf2主要存在于细胞质中,而磷酸化形式则优先定位于细胞核中。核Nrf2可以在体外被λ磷酸酶去磷酸化并转化为迁移较快的形式,这意味着Nrf2的磷酸化参与了该蛋白的细胞质-核转运。从羧基末端和氨基末端进行的缺失分析揭示了转录激活(TA)结构域Neh4(Nrf2-ECH同源性4)和Neh5(Nrf2-ECH同源性5)是磷酸化所必需的主要区域。TA结构域的特征是存在酪蛋白激酶2(CK2)的多个磷酸化位点。此外,CK2在体外使TA结构域磷酸化。用CK2抑制剂2-二甲基氨基-4,5,6,7-四溴-1H-苯并咪唑(DMAT)处理可阻断细胞中Nrf2内源性靶基因的诱导,并在很大程度上抑制Nrf2全长和TA结构域的TA活性。最后,TA结构域的磷酸化与Nrf2的核转运相关,DMAT以浓度依赖性方式抑制了该转运。这些发现表明,CK2在TA结构域对Nrf2的磷酸化是Nrf2激活的一个不可或缺的组成部分,这对于神经母细胞瘤细胞中Nrf2的核定位和转录激活功能是必需的。